Back to Search
Start Over
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine.
- Source :
-
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2004 Sep; Vol. 44 (3), pp. 302-9. - Publication Year :
- 2004
-
Abstract
- The mechanisms involved in the cardioprotector effect of red wine have not yet been completely elucidated but probably an endothelium-dependent vasodilator action may play a significant role in this effect. Experiments were undertaken to determine whether a Brazilian red wine (BRW) induces vasodilation in the mesenteric vascular bed (MVB) and an antihypertensive effect was also assessed in rats with NO-deficient hypertension. In MVB precontracted with norepinephrine, BRW (alcohol-free lyophilized) induces a long-lasting endothelium-dependent vasodilation that is not reduced by indomethacin. Inhibition of NO-synthase by NG-nitro-L-arginine methyl ester (L-NAME) and guanylyl cyclase by 1H-[1,2,3] oxadiazolo [4,4-a]quinoxalin-1-one (ODQ) reduces the vasodilator effect of BRW. In vessels precontracted with norepinephrine and depolarized with KCl (25 Mm) or treated with Ca-dependent K channel blockers charybdotoxin (ChTx) plus apamin, the effect of BRW was significantly reduced. However, this effect is not affected by ATP-dependent K (KATP) channel blocker (glibenclamide). The residual vasodilator effect of BRW observed in vessels pretreated with ChTx plus apamin is completely abolished by ChTx plus apamin plus L-NAME. Concentrations of atropine, pyrilamine, yohimbine, and HOE 140 that significantly reduced the vasodilator effect of acetylcholine, histamine, clonidine, and bradykinin, respectively did not change the vasodilator effect of BRW. Chronic oral administration of BRW induced a significant reduction in systolic, mean and diastolic arterial pressure in rats with L-NAME hypertension. The present results demonstrated that vasodilator effect of BRW is dependent on endothelium-derived hyperpolarizing factor (EDHF) in combination with nitric oxide (NO). The antihypertensive effect of red wine demonstrated in the present study may play a significant role on the cardioprotective action of chronic red wine consumption.
- Subjects :
- Acetylcholine antagonists & inhibitors
Acetylcholine pharmacology
Administration, Oral
Animals
Apamin pharmacology
Atropine pharmacology
Blood Pressure drug effects
Bradykinin pharmacology
Brazil
Charybdotoxin pharmacology
Clonidine antagonists & inhibitors
Clonidine pharmacology
Deoxycholic Acid pharmacology
Drug Therapy, Combination
Flavonoids analysis
Flavonoids antagonists & inhibitors
Flavonoids pharmacology
Glyburide pharmacology
Guanylate Cyclase antagonists & inhibitors
Hypertension chemically induced
Indomethacin pharmacology
Male
Mesenteric Arteries drug effects
Muscle, Smooth, Vascular drug effects
NG-Nitroarginine Methyl Ester adverse effects
Nitric Oxide Synthase antagonists & inhibitors
Nitroglycerin pharmacology
Norepinephrine pharmacology
Oxadiazoles chemistry
Oxadiazoles pharmacology
Perfusion
Phenols analysis
Phenols antagonists & inhibitors
Phenols pharmacology
Polyphenols
Potassium Chloride pharmacology
Pressure
Pyrilamine pharmacology
Quinazolines chemistry
Quinazolines pharmacology
Quinoxalines pharmacology
Rats
Rats, Wistar
Vasoconstriction drug effects
Vasodilation drug effects
Wine adverse effects
Yohimbine pharmacology
Alcohol Drinking adverse effects
Bradykinin analogs & derivatives
Endothelium, Vascular physiology
Hypertension prevention & control
Vasodilation physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0160-2446
- Volume :
- 44
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of cardiovascular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 15475826
- Full Text :
- https://doi.org/10.1097/01.fjc.0000133060.10597.3c